# Vertex Pharmaceuticals Incorporated (VRTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VRTX)

## Price

| Indicator | Value |
| --- | --- |
| Current Price | $ 449.36 |
| Market Cap | $ 114.05B |

## Valuation

| Indicator | Value |
| --- | --- |
| P/E10 | 49.76 |
| P/FCF10 | 245.10 |
| PEG | 4.98 |
| PFCF-PEG | 21.46 |

Widest P/E window this company has the history to fill: 15 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.10 |
| Liabilities / Eq | 0.37 |
| Current Ratio | 3.02 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 2.51 |
| Gross Debt / FCF | 4.27 |

## Other views

- [Charts](https://sponda.capital/en/VRTX/charts.md)
- [Fundamentals](https://sponda.capital/en/VRTX/fundamentals.md)
- [Compare](https://sponda.capital/en/VRTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.